Cannara Biotech Inc. (TSXV:LOVE)

Model N Balance Sheet

Financials in millions CAD. Fiscal year is September - August.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 31, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021	Aug 31, 2020
Cash & Equivalents	14.41	6.62	4.27	12.11	8.16	7.77
Cash & Short-Term Investments	14.41	6.62	4.27	12.11	8.16	7.77
Cash Growth	163.66%	55.02%	-64.75%	48.48%	4.99%	-70.68%
Accounts Receivable	14.09	13.04	10.59	8.62	2.92	0.06
Other Receivables	-	-	-	-	0.05	0.25
Receivables	14.09	13.04	10.59	8.62	2.97	0.31
Inventory	48.99	40.07	33.77	18.98	7.41	2.24
Prepaid Expenses	1.56	2.85	3.06	1.28	0.71	0.21
Other Current Assets	4.95	4.9	-	-	-	-
Total Current Assets	84	67.47	51.7	40.99	19.25	10.53
Property, Plant & Equipment	85.35	84.94	89.44	83.4	71.75	43.64
Other Intangible Assets	-	-	-	-	-	0.16
Long-Term Accounts Receivable	-	-	-	-	0.07	0.07
Long-Term Deferred Tax Assets	-	1.95	-	-	-	-
Long-Term Deferred Charges	-	-	0.06	-	-	-
Other Long-Term Assets	0.73	0.36	0.33	1.22	0.95	0.44
Total Assets	170.09	154.72	141.52	125.62	92.02	54.85
Accounts Payable	11.71	9.5	8.12	8.85	6.19	2.76
Accrued Expenses	9.45	7.86	6.86	0.77	0.07	0.16
Short-Term Debt	6.76	6.26	3	-	-	-
Current Portion of Long-Term Debt	6.28	2.97	2.97	1.97	0.3	0.3
Current Portion of Leases	0.29	0.28	0.08	0.22	0.23	0.21
Current Unearned Revenue	0.13	0.13	0.16	0.05	0.04	0.05
Total Current Liabilities	34.62	27	21.18	11.86	6.83	3.48
Long-Term Debt	33.97	38.45	39.64	46.19	20.15	11.98
Long-Term Leases	0.18	0.37	0.1	0.02	0.22	0.44
Long-Term Unearned Revenue	0.89	0.94	0.86	0.82	0.71	0.51
Other Long-Term Liabilities	-	-	-	-	-	0.08
Total Liabilities	71.49	66.77	61.78	58.88	27.91	16.49
Common Stock	89.76	88.52	88.8	83.3	83.21	58.36
Additional Paid-In Capital	11.96	12.33	10.35	9.72	9.41	7.03
Retained Earnings	-3.14	-12.9	-19.34	-26.3	-28.61	-27.08
Comprehensive Income & Other	-	-	-0.07	0.02	0.1	0.05
Total Common Equity	98.59	87.95	79.74	66.74	64.12	38.36
Shareholders' Equity	98.59	87.95	79.74	66.74	64.12	38.36
Total Liabilities & Equity	170.09	154.72	141.52	125.62	92.02	54.85
Total Debt	47.47	48.33	45.78	48.39	20.9	12.94
Net Cash (Debt)	-33.06	-41.71	-41.51	-36.28	-12.74	-5.16
Net Cash Per Share	-0.36	-0.46	-0.46	-0.41	-0.17	-0.07
Filing Date Shares Outstanding	91.43	90.02	90.02	87.7	87.65	73.78
Total Common Shares Outstanding	91.43	90.02	90.31	87.7	87.65	73.77
Working Capital	49.39	40.47	30.51	29.13	12.41	7.05
Book Value Per Share	1.08	0.98	0.88	0.76	0.73	0.52
Tangible Book Value	98.59	87.95	79.74	66.74	64.12	38.2
Tangible Book Value Per Share	1.08	0.98	0.88	0.76	0.73	0.52
Land	2.33	2.33	2.45	2.45	2.45	1.1
Buildings	77.31	76.71	75.48	64.3	44.79	37.63
Machinery	24.54	20.65	18.57	14.22	8.47	7.2
Construction In Progress	5.19	4.71	6.73	11.53	21.23	-

Updated Jan 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.